Cetrorelix in reproductive medicine.

Abstract

This book chapter presents the most important clinical aspects concerning the gonadotropin-releasing hormone antagonist cetrorelix and its importance in reproductive medicine. After an overview of the historical milestones in the development and establishment of cetrorelix in the context of ovarian stimulation treatment, its dosage, effects, and side effects are evaluated. The chapter terminates with a conclusion emphasizing the ease of use and the increase in patient safety because of a significantly reduced risk of ovarian hyperstimulation syndrome with cetrorelix compared with the agonist protocol.

• Authors: Sebastian Findeklee, Prof Klaus Diedrich
• Journal: F&S reports (F S Rep) Vol. 4 Issue 2 Suppl Pg. 62-64 (Jun 2023) ISSN: 2666-3341 [Electronic] United States
• PMID: 37223762 (Publication Type: Journal Article)
• Copyright: © 2022 The Authors.